Clinical Trials Browser

Phase 2 × ACE-011 × Plasma cell × Clear all

NCT00747123 2024-10-03

A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma

Phase 2 Completed

30 enrolled 15 charts

Multiple Myeloma

NCT02230917 2016-09-01

A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

Phase 2 Withdrawn

Multiple Myeloma